Clinical Trials Browser

Phase 2 × Cognitive Dysfunction × CNS × Clear all

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

NCT06051240 2024-04-12

LiBRA

Phase 2 Recruiting

84 enrolled

CNS

Brain Neoplasms, Memory Disorders, Radiation Injuries, Cognitive Dysfunction

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

Clinical Trials

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

LiBRA

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation